Iterum Therapeutics appoints Joseph Whalen to board; David Kelly named Chairman

Iterum Therapeutics plc

Joseph J. Whalen appointed as Class III director effective March 10, 2025; term expires at 2027 AGM.
Whalen joins Audit and Compensation Committees; receives annual cash retainers of $35,000 (board), $7,500 (audit), $6,000 (compensation).
David Kelly appointed Chairman of the Board effective March 10, 2025, after Ronald Hunt resigned on February 14, 2025.
Whalen's appointment restores Audit Committee to three independent members, regaining Nasdaq Listing Rule 5605(c)(2)(A) compliance.

item 5.02 item 8.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Joseph J. Whalen

Class III Director

ITRMF · Iterum Therapeutics plc

Effective: 2025-03-10
Filed: March 10, 2025, 7:59 PM ET

approved the appointment of Joseph J. Whalen as a member of the Board, effective as of March 10, 2025.

Role change

David Kelly

Chairman of the Board

ITRMF · Iterum Therapeutics plc

Effective: 2025-03-10
Filed: March 10, 2025, 7:59 PM ET

the Board also appointed David Kelly, an existing director of the Board, as Chairman of the Board, effective as of March 10, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joseph J. Whalen was appointed as Class III Director at Iterum Therapeutics plc.

Action: appointed
Role: Class III Director

Exact text from the filing

approved the appointment of Joseph J. Whalen as a member of the Board, effective as of March 10, 2025.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

David Kelly was appointed as Chairman of the Board at Iterum Therapeutics plc.

Action: appointed
Role: Chairman of the Board

Exact text from the filing

the Board also appointed David Kelly, an existing director of the Board, as Chairman of the Board, effective as of March 10, 2025.

View on SEC.gov

Iterum Therapeutics plc filing history →

Source: SEC EDGAR

accession 0000950170-25-035943

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.